What You Need to Know About the Opioid Settlement Funds
States and localities are receiving more than $54 billion over nearly two decades.
Multimedia
541-560 of 1,474 results
-
-
Find Out How Much Opioid Settlement Cash Your Locality Received
You can use documents obtained by KFF Health News to see the exact dollar amounts that local governments in your state have been allocated in 2022 and 2023.
-
Opioid Settlement Payouts to Localities Made Public for First Time
KFF Health News obtained documents showing the exact dollar amounts — down to the cent — that local governments have been allocated in 2022 and 2023 to battle the ongoing opioid crisis.
Slow Your Disenroll
Episode 302More than a million Americans have lost Medicaid coverage since pandemic protections ended. The Biden administration is asking states to slow disenrollment, but that does not mean states must listen. Meanwhile, a Supreme Court decision gives Medicaid beneficiaries the right to sue over their care, and a new deal preserves coverage of preventive services nationwide as a Texas court case continues. Rachel Cohrs of Stat, Alice Miranda Ollstein of Politico, and Sandhya Raman of CQ Roll Call join KFF Health News’ Mary Agnes Carey to discuss these issues and more. Also this week, KFF Health News’ Julie Rovner interviews Dan Mendelson, CEO of Morgan Health, a new unit of JPMorgan Chase, about employers’ role in insurance coverage.
-
Biden Admin Implores States to Slow Medicaid Cuts After More Than 1M Enrollees Dropped
Secretary of Health and Human Services Xavier Becerra is asking states to make more of an effort to keep eligible Medicaid recipients enrolled. He particularly fears children losing health insurance coverage.
By Hannah Recht -
What Does a Chatbot Know About Eating Disorders? Users of a Help Line Are About to Find Out
The National Eating Disorders Association’s help line has seen demand climb to unsustainable levels since the beginning of the covid pandemic, with more people reporting severe mental health problems, the nonprofit says. But staffers worry this chatbot may make things worse.
Debt Deal Leaves Health Programs (Mostly) Intact
Episode 301The bipartisan deal to extend the U.S. government’s borrowing authority includes future cuts to federal health agencies, but they are smaller than many expected and do not touch Medicare and Medicaid. Meanwhile, Merck & Co. becomes the first drugmaker to sue Medicare officials over the federal health insurance program’s new authority to negotiate drug prices. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Lauren Weber of The Washington Post, and Jessie Hellmann of CQ Roll Call join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews KFF Health News senior correspondent Sarah Jane Tribble, who reported the latest KFF Health News-NPR “Bill of the Month” feature, about the perils of visiting the U.S. with European health insurance.
A ‘Payday Loan’ From a Health Care Behemoth
Season 9, Episode 7UnitedHealth Group is the largest health insurer in the United States. And it keeps growing. This has led some health care experts to call for antitrust regulation of this “behemoth” company.
Our 300th Episode!
Episode 300When KFF Health News’ “What the Health?” podcast launched in 2017, Republicans in Washington were engaged in an (ultimately unsuccessful) campaign to “repeal and replace” the Affordable Care Act. The next six years would see a pandemic, increasingly unaffordable care, and a health care workforce experiencing unprecedented burnout. In the podcast’s 300th episode, host and chief Washington correspondent Julie Rovner explores the past and possible future of the U.S. health care system with three prominent “big thinkers” in health policy: Ezekiel Emanuel of the University of Pennsylvania, Jeff Goldsmith of Health Futures, and Farzad Mostashari of Aledade.
-
Watch: Payback for the Opioid Crisis: How Did the Sackler Family Skirt Liability?
KFF Health News senior correspondent Aneri Pattani appeared on PBS NewsHour to discuss the ruling surrounding drugmaker Purdue Pharma's role in the opioid crisis and her reporting into the ongoing distribution of opioid settlement funds.
-
As Medicaid Purge Begins, ‘Staggering Numbers’ of Americans Lose Coverage
In what’s known as the Medicaid “unwinding,” states are combing through rolls to decide who stays and who goes. But the overwhelming majority of people who have lost coverage so far were dropped because of technicalities, not because officials determined they are no longer eligible.
By Hannah Recht -
Many People Living in the ‘Diabetes Belt’ Are Plagued With Medical Debt
The “Diabetes Belt,” as defined by the Centers for Disease Control and Prevention, comprises 644 mostly Southern counties where diabetes rates are high. Of those counties, KFF Health News and NPR found, more than half also have high levels of medical debt.
When an Anti-Vaccine Activist Runs for President
Episode 299Robert F. Kennedy Jr.’s official entry into the presidential race poses a thorny challenge for journalists: how to cover a candidate who’s opposed to vaccines without amplifying misinformation. And South Carolina becomes the latest state in the South to ban abortion after roughly six weeks of pregnancy. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KFF Health News senior correspondent Aneri Pattani about her project to track the billions of dollars coming from opioid makers to settle lawsuits.
-
A Trans Teen No Longer Feels Welcome in Florida. So She Left.
Josie sensed Florida lawmakers were threatening her health care and ability to be herself at school. So she left. Families of other trans youth are plotting exits as well.
-
Picture of Health
Young People Are Having Less Sex Than Their Parents Did at Their Age. Researchers Explore Why.
The percentage of young adults not having sex was rising even before covid made dating harder. Data and research suggest economic precarity, technology, and the warping effects of porn on sexual attitudes may play a role.
The Abortion Pill Goes Back to Court
Episode 298A three-judge appeals court panel heard testimony this week about revoking the FDA’s 22-year-old approval of a key pill used in medication abortion and miscarriage management. The judges all have track records of siding with abortion foes. Meanwhile, as the standoff over raising the federal debt ceiling continues in Washington, a major sticking point is whether to impose work requirements on recipients of Medicaid coverage. Victoria Knight of Axios, Rachel Roubein of The Washington Post, and Sandhya Raman of CQ Roll Call join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.
-
Watch: 5th Circuit Judges Question Two-Decade-Old Approval of Abortion Pill
The 5th Circuit Court of Appeals in New Orleans heard oral arguments Wednesday in a case brought by conservative Christian abortion opponents seeking to revoke FDA approval of mifepristone, a medication used in more than half of abortions in the U.S.
By Sarah Varney -
State Lawmakers Eye Forced Treatment to Address Overlap in Homelessness and Mental Illness
Democratic politicians in California and Oregon are reconsidering the restrictions of involuntary commitment laws. They argue that not helping people who are seriously ill and living in squalor on the streets is inhumane.
-
A Rural County’s Choice: Use Opioid Funds to Pay Off Debt, or Pay Them Forward to Curb Crisis
Greene County, Tennessee, so far has received more than $2.7 million from regional and national settlements with opioid manufacturers and distributors. But most of the money is not going to help people and families harmed by addiction.
The Crisis Is Officially Ending, but Covid Confusion Lives On
Episode 297The public health emergency declaration for covid-19 ends May 11, ushering in major changes in how Americans can access and pay for the vaccines, treatments, and tests particular to the culprit coronavirus. But not everyone will experience the same changes, creating a confusing patchwork of coverage — not unlike health coverage for other diseases. Meanwhile, outside advisers to the FDA formally recommended allowing a birth control pill to be sold without a prescription. If the FDA follows the recommendation, it would represent the first over-the-counter form of hormonal contraception. Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KFF Health News’ Julie Rovner to discuss these issues and more. Plus for “extra credit” the panelists suggest health policy stories they read this week they think you should read, too.